225 related articles for article (PubMed ID: 21931769)
1. Suppression of breast tumor growth and metastasis by an engineered transcription factor.
Beltran AS; Russo A; Lara H; Fan C; Lizardi PM; Blancafort P
PLoS One; 2011; 6(9):e24595. PubMed ID: 21931769
[TBL] [Abstract][Full Text] [Related]
2. Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors.
Beltran A; Parikh S; Liu Y; Cuevas BD; Johnson GL; Futscher BW; Blancafort P
Oncogene; 2007 Apr; 26(19):2791-8. PubMed ID: 17057734
[TBL] [Abstract][Full Text] [Related]
3. Reactivation of MASPIN in non-small cell lung carcinoma (NSCLC) cells by artificial transcription factors (ATFs).
Beltran AS; Blancafort P
Epigenetics; 2011 Feb; 6(2):224-35. PubMed ID: 20948306
[TBL] [Abstract][Full Text] [Related]
4. Reprogramming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor.
Beltran AS; Sun X; Lizardi PM; Blancafort P
Mol Cancer Ther; 2008 May; 7(5):1080-90. PubMed ID: 18483297
[TBL] [Abstract][Full Text] [Related]
5. Targeting serous epithelial ovarian cancer with designer zinc finger transcription factors.
Lara H; Wang Y; Beltran AS; Juárez-Moreno K; Yuan X; Kato S; Leisewitz AV; Cuello Fredes M; Licea AF; Connolly DC; Huang L; Blancafort P
J Biol Chem; 2012 Aug; 287(35):29873-86. PubMed ID: 22782891
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.
Keklikoglou I; Koerner C; Schmidt C; Zhang JD; Heckmann D; Shavinskaya A; Allgayer H; Gückel B; Fehm T; Schneeweiss A; Sahin O; Wiemann S; Tschulena U
Oncogene; 2012 Sep; 31(37):4150-63. PubMed ID: 22158050
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer.
Piperigkou Z; Franchi M; Götte M; Karamanos NK
Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis.
Zhu S; Wu H; Wu F; Nie D; Sheng S; Mo YY
Cell Res; 2008 Mar; 18(3):350-9. PubMed ID: 18270520
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen induces the expression of maspin through estrogen receptor-alpha.
Liu Z; Shi HY; Nawaz Z; Zhang M
Cancer Lett; 2004 Jun; 209(1):55-65. PubMed ID: 15145521
[TBL] [Abstract][Full Text] [Related]
10. Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype.
Villares GJ; Zigler M; Dobroff AS; Wang H; Song R; Melnikova VO; Huang L; Braeuer RR; Bar-Eli M
Proc Natl Acad Sci U S A; 2011 Jan; 108(2):626-31. PubMed ID: 21187389
[TBL] [Abstract][Full Text] [Related]
11. Maspin regulates hypoxia-mediated stimulation of uPA/uPAR complex in invasive breast cancer cells.
Amir S; Margaryan NV; Odero-Marah V; Khalkhali-Ellis Z; Hendrix MJ
Cancer Biol Ther; 2005 Apr; 4(4):400-6. PubMed ID: 15846059
[TBL] [Abstract][Full Text] [Related]
12. Role of cytoplasmic localization of maspin in promoting cell invasion in breast cancer with aggressive phenotype.
Sakabe T; Wakahara M; Shiota G; Umekita Y
Sci Rep; 2021 May; 11(1):11321. PubMed ID: 34059749
[TBL] [Abstract][Full Text] [Related]
13. Snail transcription factor negatively regulates maspin tumor suppressor in human prostate cancer cells.
Neal CL; Henderson V; Smith BN; McKeithen D; Graham T; Vo BT; Odero-Marah VA
BMC Cancer; 2012 Aug; 12():336. PubMed ID: 22857708
[TBL] [Abstract][Full Text] [Related]
14. miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer.
Augoff K; McCue B; Plow EF; Sossey-Alaoui K
Mol Cancer; 2012 Jan; 11():5. PubMed ID: 22289355
[TBL] [Abstract][Full Text] [Related]
15. ATF-2 controls transcription of Maspin and GADD45 alpha genes independently from p53 to suppress mammary tumors.
Maekawa T; Sano Y; Shinagawa T; Rahman Z; Sakuma T; Nomura S; Licht JD; Ishii S
Oncogene; 2008 Feb; 27(8):1045-54. PubMed ID: 17700520
[TBL] [Abstract][Full Text] [Related]
16. Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.
Patel JB; Appaiah HN; Burnett RM; Bhat-Nakshatri P; Wang G; Mehta R; Badve S; Thomson MJ; Hammond S; Steeg P; Liu Y; Nakshatri H
Oncogene; 2011 Mar; 30(11):1290-301. PubMed ID: 21057539
[TBL] [Abstract][Full Text] [Related]
17. Expression and regulation of tumor suppressor gene maspin in breast cancer.
Maass N; Nagasaki K; Ziebart M; Mundhenke C; Jonat W
Clin Breast Cancer; 2002 Oct; 3(4):281-7. PubMed ID: 12425757
[TBL] [Abstract][Full Text] [Related]
18. Modeling human breast cancer metastasis in mice: maspin as a paradigm.
Shi HY; Zhang W; Liang R; Kittrell F; Templeton NS; Medina D; Zhang M
Histol Histopathol; 2003 Jan; 18(1):201-6. PubMed ID: 12507299
[TBL] [Abstract][Full Text] [Related]
19. Nuclear location of tumor suppressor protein maspin inhibits proliferation of breast cancer cells without affecting proliferation of normal epithelial cells.
Machowska M; Wachowicz K; Sopel M; Rzepecki R
BMC Cancer; 2014 Feb; 14():142. PubMed ID: 24581141
[TBL] [Abstract][Full Text] [Related]
20. Multiple functions of maspin in tumor progression and mouse development.
Zhang M
Front Biosci; 2004 Sep; 9():2218-26. PubMed ID: 15353283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
